Efficacy of cyto-chex blood preservative for delayed manual CD4 testing using dynal T4 quant CD4 test among HIV-infected persons in Zambia

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 2, 2006, Pages 168-174

  Truett, April A ^a   Letizia, Andrew ^a   Malyangu, Evans ^b   Sinyangwe, Frank ^b   Morales, Brandi N ^a   Crum, Nancy F ^a   Crowe, Suzanne M ^c  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b Maina Soko Military Hospital   (Zambia)

^c MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

Blood preservation; CD4 lymphocyte count; Cyto Chex (Streck Laboratories, La Vista, NE); Developing countries; Dynabeads (Dynal Biotech, Oslo, Norway); HIV; Resource constrained countries

Indexed keywords

EDETIC ACID; PRESERVATIVE;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; CD4 LYMPHOCYTE COUNT; DEMOGRAPHY; DEVICE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STORAGE TEMPERATURE; ZAMBIA; BLOOD; CD4+ T LYMPHOCYTE; COMPARATIVE STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; TEMPERATURE; TIME;

ADULT; BLOOD PRESERVATION; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; TEMPERATURE; TIME FACTORS; ZAMBIA;

EID: 33645279028     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000191282.77954.fc     Document Type: Article

References (21)

1. World Health Organization. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. 2003 Revision. Available at: http://www.who.int/3by5/publications/documents/arv_guidelines/en/. Accessed December 22, 2004.
2. Crowe S, Turnbull S, Oelrichs R, et al. Monitoring of human immunodeficiency virus infection in resource-constrained countries. Clin Infect Dis. 2003;37(Suppl 1):S25-S35.
3. Diagbouga S, Chazallon C, Kazatchkine MD, et al. Successful implementation of a low-cost method for enumerating CD4+ T lymphocytes in resource-limited settings: the ANRS 12-26 study. AIDS. 2003;17:2201-2208.
4. Didier JM, Kazatchkine MD, Demouchy C, et al. Comparative assessment of five alternative methods for CD4+ T-lymphocyte enumeration for implementation in developing countries. J Acquir Immune Defic Syndr. 2001;26:193-195.
5. Lyamuya EF, Kagoma C, Mbena EC, et al. Evaluation of the FACScount, TRAx CD4 and Dynabeads methods for CD4 lymphocyte determination. J Immunol Methods. 1996;195:103-112.
6. Landay A, Ho JL, Hom D, et al. A rapid manual method for CD4+ T-cell quantitation for use in developing countries. AIDS. 1993;7:1565-1568.
7. Gernow A, Lisse IM, Böttiger B, et al. Determination of CD4+ and CD8+ lymphocytes with the cytosphere assay: a comparative study with flow cytometry and the immunoalkaline phosphatase method. Clin Immunol Immunopathol. 1995;76:135-141.
8. Childs CR, Helm K, Bryant M, et al. Storage of processed cord blood samples prior to staining for white blood subsets [abstract]. Cytotherapy. 1999;1:231.
9. Schumacher MJ, Burkhead T. Stability of fresh and preserved fetal and adult lymphocyte cell surface markers. J Clin Lab Anal. 2000;14:320-326.
10. Turpen PB, Collins M. A reagent for stabilizing blood samples. Am Clin Lab. 1996;15:30-31.
11. Glencross D, Scott LE, Jani IV, et al. CD45-assisted panLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry. 2002;50:69-77.
12. Jani IV, Janossy G, Iqbal A, et al. Affordable CD4+ T cell counts by flow cytometry: II: the use of fixed whole blood in resource-poor settings. J Immunol Methods. 2001;257:145-154.
13. Shafaie A, Bergeron M, Phaneuf S, et al. A robust whole blood preparation for absolute counting. Cytometry. 2000;(Suppl 10):145. Abstract.
14. Shafaie A, Bergeron M, Mandy F, et al. TransFixed whole blood may be a QC solution for the single platform cell enumeration. Cytometry. 2000;(Suppl 10):146. Abstract.
15. Barnett D, Granger V, Pockley AG, et al. TransFix: a clinical sample stabilizing fluid for use in cellular haematology and immunology Cytometry. 1999;38:88. Abstract.
16. Mwaba P, Cassol S, Pilon R, et al. Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients. Lancet. 2003;362:1459-1460.
17. Shapiro HM, Mandy FF, Rinke de Wit TF, et al. Dried blood spot technology for CD4+ T-cell counting. Lancet. 2004;363:164. Correspondence.
18. Johnson D, Hirschkorn D, Busch MP. Evaluation of four alternative methodologies for determination of absolute CD4+ lymphocyte counts. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:522-530.
19. Moss MW, Carella AV, Provost V, et al. Comparison of absolute CD4+ lymphocyte counts determined by enzyme immunoassay (TRAx CD4 test kit) and flow cytometry. Clin Diagn Lab Immunol. 1996;3:371-373.
20. Paxton H, Pins M, Denton G, et al. Comparison of CD4 cell count by a simple enzyme-linked immunosorbent assay using the TRAx CD4 test kit and by flow cytometry and hematology. Clin Diagn Lab Immunol. 1995;2:104-114.
21. Saah AJ, Spruill C, Hoover DR, et al. Helper T-lymphocyte count: TRAx CD4 test kit versus conventional flow cytometry. Arch Pathol Lab Med. 1997;121:960-962.